Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Q4 Operating Loss Widens To SEK 14.0 Mln

Feb 21 (Reuters) - Kancera AB  KANC.ST :
    * Q4 OPERATING LOSS SEK 14.0 MILLION VERSUS LOSS SEK 12.7
MILLION
YEAR AGO

Source text for Eikon:  ID:nMFN980LQd 
Further company coverage:  KANC.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Novakand Pharma AB

See all news